Chromosome 10q26 locus and age-related macular degeneration: A progress update

Experimental Eye Research

Volumn 119, Issue , 2014, Pages 1-7

  Wang, Gaofeng ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; ARMS2; Gene annotation; HTRA1; Indel; PLEKHA1; Promoter; Single nucleotide polymorphism; Transcript splice variants

Indexed keywords

AGE RELATED MACULOPATHY SUSCEPTIBILITY 2; HIGH TEMPERATURE REQUIREMENT A SERINE PEPTIDASE 1; PEPTIDES AND PROTEINS; PLECKSTRIN HOMOLOGY DOMAIN CONTAINING FAMILY A MEMBER 1; UNCLASSIFIED DRUG;

AUTOSOME; CHROMOSOME 10Q26; CODING; EXPRESSED SEQUENCE TAG; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE-RELATED MACULAR DEGENERATION; ARMS2; GENE ANNOTATION; HTRA1; INDEL; PLEKHA1; PROMOTER; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPT SPLICE VARIANTS;

ALLELES; CHROMOSOMES, HUMAN, PAIR 10; EYE PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION;

EID: 84890216232     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.11.009     Document Type: Review

References (77)

1. Ambati J., Fowler B.J. Mechanisms of age-related macular degeneration. Neuron 2012, 75:26-39.
2. Andreoli M.T., et al. Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. Am. J. Ophthalmol. 2009, 148:869-874.
3. Ashurst J.L., Collins J.E. Gene annotation: prediction and testing. Annu. Rev. Genomics Hum. Genet. 2003, 4:69-88.
4. Baldi A., et al. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 2002, 21:6684-6688.
5. Bergeron-Sawitzke J., et al. Multilocus analysis of age-related macular degeneration. Eur. J. Hum. Genet. 2009, 17:1190-1199.
6. Bolognani F., Perrone-Bizzozero N.I. RNA-protein interactions and control of mRNA stability in neurons. J.Neurosci. Res. 2008, 86:481-489.
7. Chakravarthy U., et al. ARMS2 increases the risk of early and late age-related macular degeneration in the European eye study. Ophthalmology 2013, 120:342-348.
8. Chamary J.V., et al. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat. Rev. Genet. 2006, 2:98-108.
9. Chan C.C., et al. Human HtrA1 in the archived eyes with age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 2007, 105:92-97. Discussion 97-8.
10. Chang Y.F., et al. The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem. 2007, 76:51-74.
11. Cheng Y., et al. Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy. PLoS One 2013, 8:e53665.
12. Chien J., et al. Acandidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 2004, 23:1636-1644.
13. Chien J., et al. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J.Clin. Investig. 2006, 116:1994-2004.
14. Chowers I., et al. Sequence variants in HTRA1 and LOC387715/ARMS2 andphenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol. Vis. 2008, 14:2263-2271.
15. Conley Y.P., et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum. Mol. Genet. 2006, 15:3206-3218.
16. Deangelis M.M., et al. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 2008, 115:1209-1215.
17. Dewan A., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992.
18. Ding X., et al. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28:1-18.
19. Edwards A.O., et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
20. Fisher S.A., et al. Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet. 2005, 14:2257-2264.
21. Francis P.J., et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 2007, 63:212-218.
22. Francis P.J., et al. Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. Hum. Mol. Genet. 2008, 17:2673-2680.
23. Friedrich U., et al. Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency. Hum. Mol. Genet. 2011, 20:1387-1399.
24. Fritsche L.G., et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat. Genet. 2008, 40:892-896.
25. Fritsche L.G., et al. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439.
26. Fuse N., et al. Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration. Am. J. Ophthalmol. 2011, 151:550-556.
27. Gorin M.B. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol. Asp. Med. 2012, 33:467-486.
28. Hadley D., et al. Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Investig. Ophthalmol. Vis. Sci. 2010, 51:2191-2196.
29. Hageman G.S., et al. Acommon haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7227-7232.
30. Haines J.L., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
31. Hara K., et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N.Engl. J. Med. 2009, 360:1729-1739.
32. Harrington J.J., et al. Creation of genome-wide protein expression libraries using random activation of gene expression. Nat. Biotechnol. 2001, 19:440-445.
33. Hayashi H., et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Investig. Ophthalmol. Vis. Sci. 2010, 51:5914-5919.
34. Hornbeck P.V., et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucl. Acids Res. 2012, 40:D261-D270.
35. Jacobo S.M., et al. Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1. Mol. Cell Biol. 2013, 33:1976-1990.
36. Jakobsdottir J., et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 2005, 77:389-407.
37. Jones A., et al. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 35:14578-14583.
38. Kanda A., et al. Avariant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16227-16232.
39. Kanda A., et al. Age-related macular degeneration-associated variants at chromosome 10q26 do not significantly alter ARMS2 and HTRA1 transcript levels in the human retina. Mol. Vis. 2010, 16:1317-1323.
40. Klein R.J., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
41. Kortvely E., et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Investig. Ophthalmol. Vis. Sci. 2010, 51:79-88.
42. Lagnado C.A., et al. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell Biol. 1994, 14:7984-7995.
43. Launay S., et al. HtrA1-dependent proteolysis of TGF-beta controls both neuronal maturation and developmental survival. Cell Death Differ. 2008, 15:1408-1416.
44. Lavner Y., Kotlar D. Codon bias as a factor in regulating expression via translation rate in the human genome. Gene 2005, 1:127-138.
45. Liu M.M., et al. Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum. Genomics 2012, 6:13.
46. Minor E.A., et al. AMD-associated variants at the chromosome 10q26 locus and the stability ofARMS2 transcripts. Investig. Ophthalmol. Vis. Sci. 2013, 54(8):5913-5919.
47. Mori K., et al. Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J.Hum. Genet. 2007, 52:636-641.
48. Mount S.M. Genomic sequence, splicing, and gene annotation. Am. J. Hum. Genet. 2000, 67:788-792.
49. Newman A.M., et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012, 2:16.
50. Oka C., et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 2004, 131:1041-1053.
51. Pahl L., et al. Characterization of the 10q26-orthologue in rhesus monkeys corroborates a functional connection between ARMS2 and HTRA1. Exp. Eye Res. 2012, 98:75-78.
52. Richardson A.J., et al. An intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene indicates association with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2010, 51:4932-4936.
53. Rivera A., et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 2005, 14:3227-3236.
54. Ross R.J., et al. The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Investig. Ophthalmol. Vis. Sci. 2007, 48:1128-1132.
55. Sauna Z.E., Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 2011, 10:683-691.
56. Schmidt S., et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet. 2006, 78:852-864.
57. Seddon J.M., et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007, 297:1793-1800.
58. Shastry B.S., et al. Further support for the common variants in complementfactor H (Y402H) and LOC387715 (A69S) genes as major risk factors for the exudative age-related macular degeneration. Ophthalmologica 2006, 220:291-295.
59. Shiga A., et al. Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Hum. Mol. Genet. 2011, 20:1800-1810.
60. Sundaresan P., et al. Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study. Investig. Ophthalmol. Vis. Sci. 2012, 53:7492-7497.
61. Szafranski K., et al. Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns. Genome Biol. 2007, 8:R154.
62. Tam P.O., et al. HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH. Investig. Ophthalmol. Vis. Sci. 2008, 49:2357-2365.
63. Tian J., et al. Association of genetic polymorphisms and age-related macular degeneration in Chinese population. Investig. Ophthalmol. Vis. Sci. 2012, 53:4262-4269.
64. Teper S.J., et al. A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland - a brief report. Med. Sci. Monit. 2012, 18:PR1-PR3.
65. Tuo J., et al. The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology 2008, 115:1891-1898.
66. Vierkotten S., et al. Overexpression of HTRA1 leads to ultra structural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS One 2011, 6:e22959.
67. Wang G., et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Investig. Ophthalmol. Vis. Sci. 2009, 50:3084-3090.
68. Wang G., et al. Analysis of the indel at the ARMS2 3' UTR in age-related macular degeneration. Hum. Genet. 2010, 127:595-602.
69. Wang G., et al. Genotype at polymorphism rs11200638 is not correlated with HTRA1 expression level. Arch. Ophthalmol. 2010, 128:1491-1493.
70. Wang G., et al. Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina. Exp. Eye Res. 2013, 112:102-105.
71. Wang G., et al. Coding variants in ARMS2 and the risk of age-related macular degeneration. JAMA Ophthalmol. 2013, 131:804-805.
72. Weger M., et al. Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a central European population. Mol. Vis. 2007, 13:1274-1279.
73. Xu Y.T., et al. Age-related maculopathy susceptibility 2 participates in the phagocytosis functions of the retinal pigment epithelium. Int. J. Ophthalmol. 2012, 5:125-132.
74. Yang Z., et al. Avariant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993.
75. Yang Z., et al. Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet. 2010, 6:e1000836.
76. Zhang L., et al. High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-β family member growth differentiation factor 6. J.Biol. Chem. 2012, 287:1520-1526.
77. Zumbrunn J., Trueb B. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 1996, 398:187-192.